• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.0/18; CORONARY DRUG-ELUTING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 3.0/18; CORONARY DRUG-ELUTING STENT SYSTEM Back to Search Results
Model Number 364490
Device Problem Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/17/2020
Event Type  malfunction  
Manufacturer Narrative
Combination product: yes.
 
Event Description
An orsiro drug-eluting stent system was selected for treatment.The orsiro 3.0/18 was placed at the proximal part of the lad.Post-dilatation was performed but too much resistance was felt during re-entering the stent with a balloon for post-dilatation.
 
Manufacturer Narrative
Combination product: yes.The complaint instruments were not returned for analysis.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.In addition, the provided angiographic material was reviewed.Review of the production documentation for the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.During lot release inspection in the compliance test, the expanded stent outer diameter is tested for a defined amount of samples from every lot.The provided angiographic material was reviewed.The implantation of all five stents in the different target lesions in the lca is shown, partly followed by post-dilatations as not all of them are recorded.The complaint events of the difficulties in crossing the complaint stents with the balloons for post-dilatation are not visible in the angiographic material.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 3.0/18
Type of Device
CORONARY DRUG-ELUTING STENT SYSTEM
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key11499399
MDR Text Key240318891
Report Number1028232-2021-01272
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/26/2022
Device Model Number364490
Device Catalogue NumberSEE MODEL NO.
Device Lot Number03200795
Was Device Available for Evaluation? No
Date Manufacturer Received04/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-